National Pharmaceutical Council

Latest from National Pharmaceutical Council

National Pharmaceutical Council Appoints Dr. Sharon Phares as Chief Scientific Officer

January 18, 2022

The National Pharmaceutical Council (NPC), a health policy research organization dedicated to the advancement of good evidence, science and medical innovation, announced the appointment of Sharon Phares, PhD, MPH, as chief scientific officer.

Kimberly Westrich on Incentivizing Value-Based Care in Benefit Design and Reimbursement Strategies

November 28, 2021

Kimberly Westrich, MA, vice president of health services research at the National Pharmaceutical Council, discusses the shift to a value-based system from a fee-for-service one and how the health care system can incentivize high-value care.

Dr Matthew Reynolds Addresses Pre-, Postpandemic Implications for Real-world Data and Research

May 20, 2021

Matthew Reynolds, PhD, vice president of real-world evidence at IQVIA, discusses findings of a recent paper with the National Pharmaceutical Council on how COVID-19 affected real-world data and research, as well as implications for future studies.

How Shared Decision-Making, Patient Decision Aids Impact Cost, Utilization

May 14, 2021

Panelists of a session at the Pharmacy Quality Alliance 2021 Annual Meeting explore how shared decision-making and patient decision aids can promote appropriate care and treatment adherence, as well as lower cost and utilization of health care services.

Dr Robert Dubois Details the Vital Importance of Increasing Healthcare Spending Discussions

November 01, 2019

Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.